264 related articles for article (PubMed ID: 20503052)
1. Involvement of Onuf's nucleus in Machado-Joseph disease: a morphometric and immunohistochemical study.
Shimizu H; Yamada M; Toyoshima Y; Ikeuchi T; Onodera O; Takahashi H
Acta Neuropathol; 2010 Oct; 120(4):439-48. PubMed ID: 20503052
[TBL] [Abstract][Full Text] [Related]
2. Motor uncoordination and neuropathology in a transgenic mouse model of Machado-Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products.
Silva-Fernandes A; Costa Mdo C; Duarte-Silva S; Oliveira P; Botelho CM; Martins L; Mariz JA; Ferreira T; Ribeiro F; Correia-Neves M; Costa C; Maciel P
Neurobiol Dis; 2010 Oct; 40(1):163-76. PubMed ID: 20510362
[TBL] [Abstract][Full Text] [Related]
3. A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.
Switonski PM; Szlachcic WJ; Krzyzosiak WJ; Figiel M
Neurobiol Dis; 2015 Jan; 73():174-88. PubMed ID: 25301414
[TBL] [Abstract][Full Text] [Related]
4. Caffeine and adenosine A(2A) receptor inactivation decrease striatal neuropathology in a lentiviral-based model of Machado-Joseph disease.
Gonçalves N; Simões AT; Cunha RA; de Almeida LP
Ann Neurol; 2013 May; 73(5):655-66. PubMed ID: 23625556
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study of neuronal intranuclear and cytoplasmic inclusions in Machado-Joseph disease.
Hayashi M; Kobayashi K; Furuta H
Psychiatry Clin Neurosci; 2003 Apr; 57(2):205-13. PubMed ID: 12667168
[TBL] [Abstract][Full Text] [Related]
6. Selective occurrence of TDP-43-immunoreactive inclusions in the lower motor neurons in Machado-Joseph disease.
Tan CF; Yamada M; Toyoshima Y; Yokoseki A; Miki Y; Hoshi Y; Kaneko H; Ikeuchi T; Onodera O; Kakita A; Takahashi H
Acta Neuropathol; 2009 Oct; 118(4):553-60. PubMed ID: 19526244
[TBL] [Abstract][Full Text] [Related]
7. Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in normal and Machado-Joseph disease brains.
Fujigasaki H; Uchihara T; Koyano S; Iwabuchi K; Yagishita S; Makifuchi T; Nakamura A; Ishida K; Toru S; Hirai S; Ishikawa K; Tanabe T; Mizusawa H
Exp Neurol; 2000 Oct; 165(2):248-56. PubMed ID: 10993685
[TBL] [Abstract][Full Text] [Related]
8. Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain.
Paulson HL; Das SS; Crino PB; Perez MK; Patel SC; Gotsdiner D; Fischbeck KH; Pittman RN
Ann Neurol; 1997 Apr; 41(4):453-62. PubMed ID: 9124802
[TBL] [Abstract][Full Text] [Related]
9. Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence.
Bichelmeier U; Schmidt T; Hübener J; Boy J; Rüttiger L; Häbig K; Poths S; Bonin M; Knipper M; Schmidt WJ; Wilbertz J; Wolburg H; Laccone F; Riess O
J Neurosci; 2007 Jul; 27(28):7418-28. PubMed ID: 17626202
[TBL] [Abstract][Full Text] [Related]
10. Regional and cellular expression of the Machado-Joseph disease gene in brains of normal and affected individuals.
Nishiyama K; Murayama S; Goto J; Watanabe M; Hashida H; Katayama S; Nomura Y; Nakamura S; Kanazawa I
Ann Neurol; 1996 Nov; 40(5):776-81. PubMed ID: 8957019
[TBL] [Abstract][Full Text] [Related]
11. Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic mice.
Nóbrega C; Nascimento-Ferreira I; Onofre I; Albuquerque D; Hirai H; Déglon N; de Almeida LP
PLoS One; 2013; 8(1):e52396. PubMed ID: 23349684
[TBL] [Abstract][Full Text] [Related]
12. Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease.
Alves S; Régulier E; Nascimento-Ferreira I; Hassig R; Dufour N; Koeppen A; Carvalho AL; Simões S; de Lima MC; Brouillet E; Gould VC; Déglon N; de Almeida LP
Hum Mol Genet; 2008 Jul; 17(14):2071-83. PubMed ID: 18385100
[TBL] [Abstract][Full Text] [Related]
13. Spinocerebellar ataxia type 3 (SCA3): thalamic neurodegeneration occurs independently from thalamic ataxin-3 immunopositive neuronal intranuclear inclusions.
Rüb U; de Vos RA; Brunt ER; Sebestény T; Schöls L; Auburger G; Bohl J; Ghebremedhin E; Gierga K; Seidel K; den Dunnen W; Heinsen H; Paulson H; Deller T
Brain Pathol; 2006 Jul; 16(3):218-27. PubMed ID: 16911479
[TBL] [Abstract][Full Text] [Related]
14. YAC transgenic mice carrying pathological alleles of the MJD1 locus exhibit a mild and slowly progressive cerebellar deficit.
Cemal CK; Carroll CJ; Lawrence L; Lowrie MB; Ruddle P; Al-Mahdawi S; King RH; Pook MA; Huxley C; Chamberlain S
Hum Mol Genet; 2002 May; 11(9):1075-94. PubMed ID: 11978767
[TBL] [Abstract][Full Text] [Related]
15. Prenatal diagnosis of Machado-Joseph disease/Spinocerebellar Ataxia Type 3 in Taiwan: early detection of expanded ataxin-3.
Tsai HF; Liu CS; Chen GD; Lin ML; Li C; Chen YY; Wang BT; Hsieh M
J Clin Lab Anal; 2003; 17(5):195-200. PubMed ID: 12938149
[TBL] [Abstract][Full Text] [Related]
16. Intranuclear inclusions, neuronal loss and CAG mosaicism in two patients with Machado-Joseph disease.
Muñoz E; Rey MJ; Milà M; Cardozo A; Ribalta T; Tolosa E; Ferrer I
J Neurol Sci; 2002 Aug; 200(1-2):19-25. PubMed ID: 12127671
[TBL] [Abstract][Full Text] [Related]
17. Neuronal intranuclear inclusions, dysregulation of cytokine expression and cell death in spinocerebellar ataxia type 3.
Evert BO; Schelhaas J; Fleischer H; de Vos RA; Brunt ER; Stenzel W; Klockgether T; Wüllner U
Clin Neuropathol; 2006; 25(6):272-81. PubMed ID: 17140157
[TBL] [Abstract][Full Text] [Related]
18. The shortest expanded allele of the MJD1 gene in a Chinese MJD kindred with autonomic dysfunction.
Gu W; Ma H; Wang K; Jin M; Zhou Y; Liu X; Wang G; Shen Y
Eur Neurol; 2004; 52(2):107-11. PubMed ID: 15316156
[TBL] [Abstract][Full Text] [Related]
19. Full-length expanded ataxin-3 enhances mitochondrial-mediated cell death and decreases Bcl-2 expression in human neuroblastoma cells.
Tsai HF; Tsai HJ; Hsieh M
Biochem Biophys Res Commun; 2004 Nov; 324(4):1274-82. PubMed ID: 15504352
[TBL] [Abstract][Full Text] [Related]
20. Compromised mitochondrial complex II in models of Machado-Joseph disease.
Laço MN; Oliveira CR; Paulson HL; Rego AC
Biochim Biophys Acta; 2012 Feb; 1822(2):139-49. PubMed ID: 22037589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
